glp-1 iih Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial The protective role of GLP-1

For a full comparison, see our guide on Wegovy in tablet form

Editado por: Silvia Pellitero-Rodrguez - University Hospital Germans Trias i Pujol Badalona Federico Vzquez Sanmiguel - University Hospital Germans Trias i Pujol Badalona ltima actualizacin : Octubre 2025 Los frmacos con accin sobre el receptor del pptido similar al glucagn tipo 1 (GLP-1) son efectivos en el tratamiento de enfermedades metablicas asociadas a la obesidad, como la apnea obstructiva del sueo (AOS), la enfermedad heptica metablica (EHMET) y la enfermedad renal crnica (ERC)

We have a commitment to delivering a discreet service and understand your need for privacy

But after we get through those two or three years, our tree starts to take root and become stronger